$CRMD breakout $2.02/$2.50 called 1/10/14 AMEX

$CRMD breakout $2.02/$2.50
called 1/10/14
AMEX




Shares Outstanding: 22.18M
Float: 19.18M
% Held by Insiders: 16.31%
% Held by Institutions: 9.20%
Shares Short (as of Dec 31, 2014): 411.97K
Short Ratio (as of Dec 31, 2014): 9.30
Short % of Float (as of Dec 31, 2014): 2.00%
Shares Short (prior month): 342.36K



10-Q 11/13/14
Summary


Recent Trades


Headlines

Tuesday, January 20, 2015
CORMEDIX INC. Files SEC form 8-K, Other EventsEDGAR Online (Tue 7:01AM EST)

Thursday, January 15, 2015
CORMEDIX INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Thu, Jan 15)
CorMedix Inc. Receives Fast Track Designation for Neutrolin®PR Newswire (Thu, Jan 15)
CorMedix (CRMD) Shows Strength: Stock Moves Up 14.6% - Tale of the TapeZacks (Thu, Jan 15)

Monday, January 12, 2015
CORMEDIX INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online (Mon, Jan 12)

Tuesday, December 23, 2014
CORMEDIX INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Tue, Dec 23)
CorMedix Inc. Finalizes First Middle East Neutrolin® Sales/Distribution Agreement in the Kingdom of Saudi ArabiaPR Newswire (Tue, Dec 23)

Thursday, December 4, 2014
CORMEDIX INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Thu, Dec 4)
CorMedix Inc. Files Request with FDA for QIDP Designation for Neutrolin®PR Newswire (Thu, Dec 4)

Wednesday, December 3, 2014
Neutrolin Label Expansion Approved in GermanyPR Newswire (Wed, Dec 3)

Friday, November 21, 2014
CORMEDIX INC. FinancialsEDGAR Online Financials (Fri, Nov 21)

Thursday, November 13, 2014
CORMEDIX INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online (Thu, Nov 13)
Q3 2014 CorMedix Inc Earnings Release - Time Not SuppliedCCBN (Thu, Nov 13)

Thursday, November 6, 2014
CorMedix, Inc. to Announce Third Quarter 2014 Results on November 13, 2014; Conference call hosted at 9 am on Friday, November 14, 2014PR Newswire (Thu, Nov 6)

Monday, October 27, 2014
CORMEDIX INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Mon, Oct 27)
CorMedix Receives Approval From FDA to Initiate a Clinical Trial for Neutrolin in the USMarketwired (Mon, Oct 27)

Thursday, September 25, 2014
CORMEDIX INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Thu, Sep 25)
CorMedix Announces FDA IND Filing for Neutrolin® in United StatesPR Newswire (Thu, Sep 25)

Monday, September 22, 2014
CORMEDIX INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Mon, Sep 22)
Neutrolin Label Expansion Approved for the European UnionPR Newswire (Mon, Sep 22)